# Open Label Extension Study of PREOS

> **NCT00172133** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 1683 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** ALX1-11 (drug)

## Key facts

- **NCT ID:** NCT00172133
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10-16
- **Primary completion:** 2005-04-13
- **Final completion:** 2005-04-13
- **Target enrollment:** 1683 (ACTUAL)
- **Last updated:** 2021-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00172133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00172133, "Open Label Extension Study of PREOS". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00172133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*